Aurigene Discovery Technologies Limited
Clinical trials sponsored by Aurigene Discovery Technologies Limited, explained in plain language.
-
New pill for advanced cancers enters first human tests
Disease control Recruiting nowThis early-stage study tests an experimental oral drug called AUR107 in 50 adults whose advanced cancers have returned or not responded to prior treatments. The main goals are to check the drug's safety, find the right dose, and see how it behaves in the body. Participants must b…
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
New pill aims to tame advanced lymphoma in early human trial
Disease control Recruiting nowThis early-stage study tests an experimental oral drug called AUR108 in 40 adults whose advanced lymphoma has returned after prior treatment. The main goals are to check the drug's safety, find the right dose, and see how the body processes it. Participants must be in fairly good…
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
New pill for tough lymphoma cancers enters first human tests
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called AUR112 in about 40 adults with relapsed advanced lymphoma (a type of blood cancer that has returned or is hard to treat). The main goals are to check the drug's safety, find the right dose, and see how the body process…
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 26, 2026 07:21 UTC